• Gary Ingenito, MD, PhD, has been named senior vice president, clinical development and regulatory affairs, for Angiotech Pharmaceuticals (Vancouver). He formerly was senior vice president of contract research organization SFBC International. Angiotech is focused on developing drug-eluting medical devices and biomaterials.

• Harry Tung, MD, has been named corporate vice president, Global Surgical, for Bausch & Lomb (B&L; Rochester, New York). Tung was formerly vice president, new business development, for Boston Scientific. Tung succeeds Kamal Sarbadhikari, who plans to retire this year after nearly 20 years with the company. B&L is an eye health company, with core businesses including contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products.

• Lee Langord has been named vice president and general manager of the Central Area for Cardiogenesis (Foothill Ranch, California). Langford previously was a regional manager for Capital Sales. Cardiogenesis is a leader in surgical products used in angina-relieving Transmyocardial Revascularization and Percutaneous Myocardial Channeling.

• CooperVision (Lake Forest, California) reported a revised management structure for its U.S. operations resulting from the acquisition of Ocular Sciences on Jan. 6. Key changes include Jeff McLean, previously vice president of sales, being named president of CooperVision's U.S. operations, while Brad Jones was named vice president of U.S. sales. CooperVision markets a range of contact lenses.

• Herbert Mertens has been named to the newly created post of vice president of sales and marketing for Endologix (Irvine, California). Mertens will oversee the U.S. launch of Endologix's Powerlink System, an endoluminal graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA). Endologix manufactures minimally invasive treatments for vascular diseases.

• John Feilders has been named president and chief operating officer for Orthosoft (Montreal). Feilders formerly was head of international operations for Biomatrix. Orthosoft Holdings develops multi-platform surgical navigation systems for the computer-assisted orthopedic surgery market.

• Stephen Fanning has been named president and CEO of Thermage (Hayward, California), a manufacturer of non-invasive treatments to tighten and contour skin. Fanning also was named to the company's board. Prior to joining Thermage, Fanning was president, CEO and a director of Ocular Sciences. Fanning replaces Robert Byrnes, leaving Thermage, to attend to family health concerns, but remains a member of company's board.